Philip Reigan

6PUBLICATIONS
14CO-AUTHORS
Molecular targetsChemical and thermal processes in energy and combustionCheminformatics and quantitative structure-activity relationshipsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 24, 2026
Chromobox 2 Inhibition: A Novel Activity of Alisertib, an Aurora A Kinase Inhibitor.

Tomomi M Yamamoto, Ritsuko Iwanaga, Elizabeth R Woodruff

|Dec 08, 2025
The structural requirements of 3,5-substituted oxindoles that determine selective AMPK or GSK3β inhibition.

Juliet E Strang, Daniel D Astridge, Caleb Chandler

|Aug 12, 2025
RiSKs in Computational Modeling of Isoform-Selective RSK Inhibitors.

Vu T Nguyen, Caleb Chandler, Juliet E Strang

|Jan 29, 2025
Small Molecule Modulators of AMP-Activated Protein Kinase (AMPK) Activity and Their Potential in Cancer Therapy.

Juliet E Strang, Daniel D Astridge, Vu T Nguyen

|Sep 02, 2021
Evaluation of Thymidine Phosphorylase Inhibitors in Glioblastoma and Their Capacity for Temozolomide Potentiation.

Becka M Warfield, Christopher J Matheson, Debbie G McArthur

|Jun 09, 2018
Development of Potent Pyrazolopyrimidinone-Based WEE1 Inhibitors with Limited Single-Agent Cytotoxicity for Cancer Therapy.

Christopher J Matheson, Kimberly A Casalvieri, Donald S Backos

Pageof 1

Frequent Collaborators

3 joint publications

Daniel D Astridge

2 joint publications

Vu T Nguyen

2 joint publications

Caleb Chandler

1 joint publications

Donald S Backos